ORGANOGENESIS HOLDINGS INC. Finance Lease, Right-of-Use Asset, Accumulated Amortization
ORGANOGENESIS HOLDINGS INC. (ORGO) had Finance Lease, Right-of-Use Asset, Accumulated Amortization of $2.83 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee › Finance Lease, Right-of-Use Asset, after Accumulated Amortization
us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization · last filed 2026-02-26
- 2025-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $2.83M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $1.63M.
- 2024-06-30: Finance Lease, Right-of-Use Asset, Accumulated Amortization $1.05M.
- 2024-03-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $767.00K.
| Period end | Finance Lease, Right-of-Use Asset, Accumulated Amortization | Finance Lease, Right-of-Use Asset, Accumulated Amortization as first filed |
|---|---|---|
| 2025-12-31 | $2.83M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $1.63M 10-K · filed 2026-02-26 | |
| 2024-06-30 | $1.05M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $767.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $479.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.37M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.17M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.17M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.17M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.17M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.07M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $961.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $16.74M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $15.58M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $15.27M 10-Q · filed 2021-05-11 | |
| 2021-01-01 | $19.25M 10-K · filed 2022-03-01 | $14.97M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |